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                                 INTRODUCTION 
                   Cancer, described popularly as a malady ascribable to the 
precipitous overgrowth of certain infinitely multiplying cells at the 
expense of the surrounding tissues, has been a domain of concern for the 
medical fraternity for ages. The achievements in the field of oncological 
research and health care have been tremendous, nevertheless, the panacea 
for this dreaded disease has been eluding the human race for centuries. 
The graveness of the disease, although is universally recognised, one 
cannot but disregard the morbidity, grievousness and disfigurements 
rendered by the current treatment modalities per se. The heartrending 
agonies, experienced by these unfortunate patients have been 
increasingly realized and a need to acknowledge various psychological 
aspects of their self-perception cannot be understated.     
Breasts and uterus constitute and exemplify the basic symbol of 
femininity and womanhood.  They are inevitable in the physical, 
physiological, emotional and psychological spheres of every woman’s 
life. Any deprivation of these organs, well-accepted as the principal 
treatment modality in diverse breast and gynecological malignancies, can 
have devastating aftermaths on the very belief of self-esteem and 
muliebrity in women, apart from the more obvious physical 
consequences. The profound impact of such circumstances on the 
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wellness of the families and society, at large, cannot merely be back 
grounded as well.      
          Malignancies of the breasts  are increasingly encountered by the 
medical practitioners worldwide. The incidence of these cancers  in India 
is 20.5/100,000.As per the epidemiological survey conducted by the 
Madras Metropolitan Cancer Registry the incidence of breast cancer in 
urban Chennai  is 31.0/100,000;  the mean age of onset for breast cancer 
is 45.5. The 5 year survival rate after completion of treatment is 65% , 
while that for partially treated and defaulted patients, it is 40%. 
Mastectomy and Lumpectomy with breast conservation are the two most 
common surgeries performed. 
            Gynecologic cancers form the other most common loci for 
malignant disease in women, the four sites commonly involved in 
descending order being endometrial, cervical, ovarian and vulvar cancers. 
The incidence of Endometrial cancer is 2.5/100,000 and that of cervical  
23.2 in India. The incidence of  endometrial cancer in urban Chennai is 
4/100,000 and that of cervix is 18/100,000 ;  the mean age of onset for 
endometrial and cervical cancer is 50 – 54 years. The 5 year survival rate 
for cervical cancer is 65 years and it is even higher in endometrial cancer. 
Total abdominal hysterectomy with bilateral salpingo-oophorectomy is a 
definitive therapy in a variety of gynecological malignancies. 
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Importance of Psycho oncology:  The field of psycho-oncology has 
emerged as a sub speciality within oncology and psychiatry.  It deals with 
the psychological, behavioral and social factors influencing the risk, 
detection, treatment and prognosis of cancer.   
    The disease and its treatment modalities evoke varied responses 
among individuals based on one’s personality factors, ego-strengths, 
coping strategies, adaptation skills and the support from the treating 
faculty, family and the society apart from the socioeconomic and socio 
cultural background. The fear of shortened life span and the approach of 
death along with the have a strong impact on their psychological 
behavior. Psychoneuroimmunological studies reveal the involvement of 
stress and hypothalamic-pituitary axis on the initiation and progression of 
psychological responses.   
    Breast cancer has a complex   impact on women.  The medical, 
psychological and psychosocial factors and the socio cultural background 
are the major factors which influence them. Prevalence of depression in 
these patients is twice as that in general  female population.   
    In case of gynecological malignancies, late presentation due to 
non-specific symptoms is an important cause for distress.  The physical 
and psychological symptoms have both independent and cumulative 
effects on them.   
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      The condition of cancer survivors is an important area to be 
focused.  They experience changes in the physical and psychological 
aspects on concept of self.  These along with psychological morbidity 
affect the quality of living in these women.           
Body Image:  One of the earliest definitions of body image by 
Schilder  is a “a picture of our own body which we form in our mind, that 
is to say the way in which the body appears to ourselves”. It is a dynamic 
construct. The various treatment modalities affect the concept of body 
image in cancer patients. Therefore it is of prime importance to address 
this issue while planning treatment as it affects the patients’ and their 
family’s quality of living. 
Quality of life:   WHO defines ‘quality of life’ as “Individual’s 
perception in the context of their culture and value system in which they 
live and in relation to their goals, expectations, standards and concerns”.  
Quality of life  covers the following domains – physical, emotional, 
social, cognitive, role and financial wellbeing.   
   Psychiatric Morbidity:   The psychiatric morbidities encountered 
frequently in cancer patients who underwent a surgical procedure as a 
part of the treatment regimen can be enumerated as the following: 
             Delirium, dementia and other cognitive disorders, Adjustment 
disorder, Anxiety disorders – PTSD, generalised anxiety disorders, panic 
attacks, and specific phobias, Depressive disorders, suicide,Cancer 
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related fatigue, Bipolar disorder, Personality disorders, Schizophrenia 
and other psychiatric disorders, Substance use disorders ,Somatoform 
disorders   Pain, Sexuality, survival rate, delayed consequences of 
treatment are  the major concerns in cancer patients. 
    Current treatment modalities focus on symptom removal and the 
physical effects of the treatment options.  Recognizing quality of life as 
an endpoint/goal of treatment has not been considered and due credit to 
this aspect has not been given till now particularly in developing 
countries. 
      Psychiatric morbidity though an obvious co-existing problem along 
with the primary disease is being underdiagnosed and neglected even if 
diagnosed.  It is essential to identify and treat psychiatric morbidities at 
the earliest stage possible and to bring about psychological well being 
along with physical well being.  This is all the more important in cases 
where psychiatric morbidity is present even before the cancer diagnosis. 
            Body image and sexuality is one sensitive area which is 
slowly receiving attention at present.  This is one area which is being 
neglected mainly because of the social, educational and cultural 
background.  With the mean age of tumor  patients being in a decline, 
this field has come into focus.    
       But a woman’s integrity and concept of self revolves around her 
body image and sexuality which in turn has a profound impact on her 
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psychological well being and quality of life in all spheres.  This also 
indirectly affects her family and society as well.   
In both breast and gynaecological malignancies, lot of studies have 
focused on the psychiatric morbidity and quality of life issues. There are 
very few studies in this part of the world focusing entirely on the context 
of body image disturbances. As uterus is considered an internal organ, it 
is believed that its removal does not have as much effect on these factors 
as its counterpart in breast and other external organs. 
This study mainly focuses on the body image disturbances and 
psychiatric morbidity in breast and gynaecological cancers and its 
influence on the various spheres of life of women.    
 
             
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
                              REVIEW OF LITERATURE 
    Cancer – its diagnosis  can lead to numerous psychological 
problems because of various factors. Apart from physical symptoms, 
constant fear of recurrence and death and   treatment uncertainty, there 
are changes in personality, self concept and sexuality, family 
circumstances and quality of life (Abasher, 2009, Dizon, 2009). 
   Numerous studies in literature have focused on feminine cancers 
and their effects on physical, emotional, social and role functioning 
including the sense of femininity, sexuality and spouse relationships.  
(Stead, 2004). Chen et al (2009) have reported increased rates of 
depression in breast and gynecological cancer patients.  The incidence of 
depressive and anxiety symptoms is noted maximum within the first year 
of diagnosis in 50% of breast cancer patients. (Den Oudsten et al, 2009).   
       Silverberg (1984) reported that breast and gynecological cancer 
women are at a high risk for sexual problems.  These two sites combined 
form 44% of female cancers diagnosed in a year.  Extensive studies have 
been conducted on psychological outcomes in breast cancer patients.  
Most of these studies have estimated the overall sexual disruption, 
decreased intercourse frequency, difficulties with orgasm from 21% to 
39% in  retrospective manner.  (Silberfarb et al, 1980).  Body image and 
marital adjustment are relevant areas common for both breast and 
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gynecological cancer patients.    The mere diagnosis of the disease itself 
shakes the fundamental faith of existence among cancer patients. 
 Breast Cancer:         
      Breast is an organ which is considered as the symbol of femininity 
and cancer in this organ as well its treatment modalities greatly affect the 
physical, mental and psychological framework of the patients.   
   Body Image is defined as a mental construct that develops since 
birth along with motor and sensory developments through exploring the 
world around.  (Schilder, 1935).   According to Sertoz et al (2009) body 
image refers to one’s  attitude, perceptions and emotions towards one’s 
own physical appearnce, self and functionality.   Body image is described 
in the cognitive, affective, behavioural and evaluative context.  Body 
image disturbances together  with poor self esteem and psychological 
morbidity   have a cumulative negative  effect on the quality of life 
(Jamison, 1978).  Bailey et al (2009) defined body image as a symbol of 
femininity, attractiveness and social expression.  They   listed the areas of 
negative body image, namely, dissatisfaction with appearance, decreased 
sense of sexual attractiveness and unwillingness to see her naked body.   
Petronis et al (2003) suggested that the body image disturbances are a 
great concern for women with breast cancer.           
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     According to   Carver et al (1998) women with breast cancer 
perceive body image in terms of lack of sense of wholeness and 
functionality.   It has been suggested by them that women who weigh self 
worth on the basis of body image may be at increased risk of 
psychosocial maladjustment after treatment for breast cancer.  The 
treatment modalities for breast cancer have also a profound impact on 
both body image and sexuality.   
   Psychological sequelae of sugery:  Two most common surgical 
treatments for breast cancer  are mastectomy and lumpectomy.  
Mastectomy, being the standard treatment, can elicit feelings of 
annihilation, decreased self-worth, decreased sexuality and loss of 
femininity.   These are  associated with fear of recurrence, abandonment 
and death.  (Rowland and Massie, 1998).  Also  increase in anxiety, 
depression, hopelessness, guilt and shame has been reported in these 
patients. W. Janni et al (2001) reported higher emotional stress and 
dissatisfaction with body image due to change in physical appearance 
after mastectomy.  More recent analyses have found better psychosexual 
outcomes with conservative surgeries.  (Yurek, 2000).  Ganz et al (1992) 
reported that there was no significant difference in quality of life or mood 
between the mastectomy and breast conservation groups.  But the latter 
had lesser problems with body image and choice of clothing.          
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Fallowfield et al (1986) reported the incidence of anxiety and depression 
to be 33% and 38% in mastectomized and breast conserved patients 
respectively.      
     de Haes and Welvaart (1985) compared the lumpectomy and 
mastectomy patients and found that the two groups  differed significantly 
in body image alone among other indices like psychological disturbances, 
physical symptoms, marital satisfaction and libidinal level.   On the other 
hand, Poulson et al (1997)  noted no  difference among these variables in 
the two groups.  A French study conducted on the factors influencing the 
choice of surgery  revealed that women who identified consideration for  
body image and sexuality chose reconstructive surgery over mastectomy. 
These patients belonged to younger age group. The study implied that 
age along with body image and sexuality had a great influence in 
deciding the choice of mode of treatment.  (Anian et al, 2004).  Fiona et 
al (2005) conducted a comparative study on coping skills and body image 
between 50 mastectomized and 25 lumpectomized female patients.  The 
former group expressed concern about body image disfigurement. 
Coping strategies effectively resolved the concerns except for sexual role 
and performance and recurrence.   They also measured the severity of 
depression and anxiety.  But the difference was not statistically 
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significant.  They concluded that the coping skills have to be 
strengthened for the effective resolution of the concerns.  
       The treatment modality for breast cancer involves apart from 
surgery, radiotherapy and chemotherapy also.   
Chemotherapy can lead to dermatitis, hair loss and weight gain. 
These features invariably have an impact on body image.  Chemotherapy 
affects the sexual functioning both directly and indirectly: directly 
through its hormonal effects and indirectly through its physical side 
effects which includes fatigue, nausea, vomiting, sleep and appetite 
disturbances (Kaplan,1992).  
      Sexuality is affected in the first year  after cancer treatment. 
(Abasher,2009).  90% of women undergoing treatment for breast cancer 
experience sexual dysfunction (Dizon, 2009).  All the four modalities of 
treatment (surgery, chemotherapy, radiotherapy and hormonal therapy) 
have an effect on sexual dysfunction.  Chemotherapy causes dyspareunia, 
vaginal dryness, and decreased sexual drive (Henson, 2002,  Lindley et al 
(1998).   The medicines given for treating psychiatric comorbidities  like 
pain, anxiety or depression also cause sexual dysfunction. (Martinez, 
2008).  The studies by   Lindley et al, 1998, Curran et al (1998)  show 
that 50 to 60% of  women undergoing chemotherapy experience sexual 
dysfunction beyond the first year indicating the severity of the effects of 
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chemotherapy.  Chemotherapy induced menopausal women experience 
more sexual dysfunctioning indicating the influence of chemotherapy on 
this factor.  (Ganz et al, 1998).  Possible mechanism as explained by    
Kaplan (1992)  is due to deficiencies of hormonal levels not only of 
estrogen but also of androgens on sexual functioning.   
Radiotherapy in the adjuvant setup has less influence on sexual 
dysfunction than chemotherapy (Steinberg, 1985, Beckmann et al 1983).  
Radiotherapy can cause skin discoloration. Other short term side effects 
like breast tenderness, skin redness and hypersensitivity may affect the 
body image. Lymphoedema, leading to arm swelling is a well recognized 
side effect of axillary radiotherapy especially when used along with 
axillary dissection.  This can have an impact on body image concept. 
(Farooqi, 2005) 
              Numerous studies on the impact of hormone or endocrine 
therapies on body image and sexuality have been conducted.   The side 
effects of such treatment include weight gain, hot flushes, nausea, vaginal 
irritation,  discharge, and dryness. (Budzaret et al,1998).  Tamoxifen is 
found to be the most common culprit.  Two thirds of women on 
tamoxifen treatment experience hot flushes   and it is noted to be severe 
in about one third of patients.  (Carpenter et al,1998). 
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          There has been inconsistent results in the area of sexual 
dysfunction with various studies reporting both increase and decrease in 
libidinal function. (Barni et al, 1998, Leonard et al, 1996).   
          Studies have not indicated any significant increase in psychiatric 
morbidity as a direct effect of hormone therapy (Ganz, 2001, Fisher et al, 
1998). Thomas Mcclean in 2005 reported the “Phantom breast 
syndrome” whose incidence out of 198 patients was found to be 23 – 
52.7% by Meyllowitz (1980). Recent studies have shown the incidence to 
be 22.9%, seen mainly in younger women and with depressive 
symptoms. (Ferreira et al, 2003).  One of the most important factor 
affecting sexual and physical functioning is pain following  surgery and 
Radiotherapy.   A study by Ghizzani et al, 1995 noted that women who 
do not attain menopause after treatment have a more effective  sexual 
functioning, including normal sexual desire and gratification and marital 
harmony.       
               Young (1996) conducted a study on breast cancer patients 
treated with adjuvant chemotherapy after control for hormonal therapy 
showing chemotherapy to be associated with significant sexual 
dysfunctions and menopausal symptoms.  They also reported more of the 
physical complications, organismic difficulties, vaginal dryness, mood 
swings, pain during sexual intercourse, weight changes and hot flushes.   
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        Longitudinal studies conducted have emphasized that in course of 
time most of the women adjust to the changes in self esteem and 
sexuality.  Few of them experience long term morbidity.  (Ganz et al, 
1998, Dorval et al, 1998). Studies by Ganz et al (1996) have revealed 
delayed onset of these symptoms highlighting the importance of timely 
assessment and intervention.  One important factor affecting 
postoperative sexual functioning is the quality of pre-operative sexual 
functioning. (Bransfield, 1982). 
         A woman’s choice of treatment is likely to be influenced by age, 
her hopes, fears and present body image status.  Some women choose 
Breast conservation therapy over modified radical mastectomy for 
cosmetic reasons.  Some choose mastectomy mainly due to fear of 
recurrence and treatment with radiotherapy regardless of the effect on 
their body image.          
  Psychosocial Issues: 
          Treatment   modalities of breast cancer, especially mastectomy 
have profound effects on spouse relationship and marital harmony apart 
from the diagnosis itself. (Isabel Pinto, 2010).  Few studies have reported 
the marital problems as a result of mastectomy, leading to divorce and 
abandonment in extreme cases (Karabulut et al, 2009, Sheppard et al, 
2008, Kalaitzi et al, 2007).                                           
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            Fallowfield (1996) reported that there  is no significant difference 
in psychiatric morbidity among patients who undergo mastectomy and 
conservative surgery.    
  Treatment related morbidities:   
           Harrison and Maguire (1994) showed that Randomised Controlled 
Trials of adjuvant chemotherapy revealed association of 
chemotherapeutic agents with excessive psychological, social and sexual 
problems.  Psychological consequences of radiotherapy  were present 
beyond six months after completion of the treatment but were lower than 
their counterparts receiving chemotherapy  where the complications are 
seen after 12 months of completion of the treatment.   Schebusch (1999) 
noted Post Traumatic Stress Disorder as a predominant symptom in those 
who were in remission. 
           Greer et al (1983) classified psychiatric morbidity in cancer into 3 
types.  
          a)  diagnosis related 
          b) treatment related  
          c) terminal phase of illness related. 
         Study by Maguire et al (1978) assessed psychiatric morbidity 
associated with mastectomy compared to control comprising of patients 
with benign breast disease from onset of diagnosis till one year after 
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treatment.  There were higher rates of prevalence of psychiatric morbidity 
in the first group.  39% of patients in the first group required treatment 
for anxiety, depression and sexual difficulties.   
             Ganz et al 1985, found anxiety and depression to be the two most 
common psychiatric disorders associated with breast cancer.  Poor social 
and emotional support, maladjustment, presence of pain and fatigue, 
reduced coping skills- form strong predictors of psychiatric problems in 
breast cancer.  This study highlights the importance of patients emotional 
reactions to illness in psychiatric morbidity.   
               The prevalence of associative disorders ranged from 1-49% 
while that of depressive disorder ranged from 1.5 – 46%.  Morasso et al 
2001).  Morris et al (1977) found that  the prevalence of depression in 
women was found to be 22% following mastectomy. 
             Various demographic factors predict the onset and prognosis of 
psychiatric morbidity (Taylor et al, 1985, Morris et al, 2001) 
             All stages of disease and treatment procedures affect 
psychological reaction of women.  The reactions vary from person to 
person in different stages .  Morris et al (1977)   found that the prevalence 
of depression in women was found  to be 22% following mastectomy.  
Various demographic  factors predict the onset and prognosis of 
psychiatric morbidity. (Morris et al 2001, Taylor et al, 1985).  
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           Undergoing treatment for breast cancer is a traumatic experience 
for women mainly due to its effects on body image, sexuality and self-
esteem.  (Yankaskas, 2005).    This is also due to the effects of the illness 
and treatment on their families and spouses. (Rabinowst, 2002).   
             For example, denial and anger in the initial stage, anxiety and 
depression at later stages affect the patients.  Treatment modalities 
mainly lead to fear of relapse/recurrence increasing the incidence of 
anxiety and depressive disorders . 
              Good social and emotional support from family and proper 
adaptive and coping skills were found to be lacking in persons diagnosed 
with anxiety and depressive symptoms. Mc Caul et al 2009.  
Depression:  
              Prevalence of depression among survivors is found to be 
between 0-38% for major depression and from 0-58% for depression 
spectrum syndrome (Massie, 2004). 
           Factors negatively influencing maladjustment to illness are  
history of depression in the past; Medical/surgical co morbidity; Low 
Socio Economic Status; side effects of illness; ineffective coping styles 
and social support;  Multiple stresses (Alfano and Rowland, 2006). 
  Grief:  
          Survivors usually focuses her grief about illness, leading to 
revisiting of previous unresolved grief (Stroebe and Schut, 1995). Risk 
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factors associated with prolonged  grief disorder are insecure attachment 
styles, parental abuse/death, separation anxiety, dependency and lack of  
marital support (Priggerson et al, 2009).   Anticipating grief may occur at 
the thought of death or treatment uncertainty (Virginea Lee et al, 2008).  
It is more common in survivors of metastatic disease. 
Anxiety:   
         American Psychiatric Association, 2000 defines anxiety as an 
emotional or physiological response to various causes, known or 
unknown ranging from a normal reaction to extreme dysfunction.   
Anxiety in survivors is attributed to the illness, treatment, and its adverse 
effects  and fear of recurrence (Amir and Ramati, 2002)  
Post Traumatic Stress Disorder(PTSD):      
       Jim and Jacobson, 2008 described PTSD as a disorder that occurs 
when an individual is unable to reconcile the shock of an event, traumatic 
in nature; with regard to core beliefs about oneself and the world.  It is 
estimated that 16-28% experience intrusive thoughts and 15-34% have 
avoidance behaviour after treatment completion.  Women with CT were 
found to be at increased risk for PTSD upto 5 years after treatment.  
(Amir and Ramati, 2002).  PTSD is found to be associated with increased 
incidence of depression and reduction in quality of life. 
          Post traumatic growth is found in 3 life domains – social resources, 
personal resources and coping skills (Jim, Jacobson, 2008).  It is 
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associated with perceived threat of death  and perceived stress of the 
illness.  Perceived threat helps in post traumatic growth if moderately 
present, otherwise if can impede the growth of the survivor.     
           Biological correlates  of  depression are being investigated 
recently.  They were studied in relation to coping styles, psychological 
status and survival . Evidence has been reported for alteration in 
circadian pattern of cortisol secretion in patients with advanced disease.  
Septon(2000)  found that flattening of diurnal cortisol slopes was  
associated  with reduced survival time in metastatic breast carcinoma. 
(42).     Turnercoff et al (2000) showed an association between level of 
social support, belonging and appraisal with cortisol level in metastatic 
breast cancer. 
            Certain physical and psychological symptoms occur due to a 
condition called ‘cytokine-induced sickness syndrome’ as a result of 
illness and treatment (Savard et al, 2000) (Example: apathy, social 
isolation, withdrawal, psychomotor retardation, cognitive disturbances). 
            Early psychological studies have shown that following radical 
mastectomy, women had significant post operative depression, anxiety 
and poor self-esteem.  (Schottenfield et al, 1970). 
           Thapa et al 2010, noted that stage of disease and quality of life 
(QOL) are predictors of  PTSD like symptoms after mastectomy.  Also 
women who received aggressive chemotherapy are prone to develop 
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PTSD.    They also reported prevalence of delirium to be 15-20% in 
patients undergoing palliative care. 
       Psychosocial issues:  Reactions to illness, adaptation and coping 
strategies are important psychosocial issues to be considered.    
Psycholgical outcome of cancer surgery is influenced by various factors 
apart from the surgical procedure and illness correlates  per se.  They 
include premorbid personality traits, coping styles, stressful life events, 
premorbid psychiatric illness, social support and the extent of surgery 
(Gunz et al, 1985).   
          Coping skills play an important  role in reaction to illness, concept 
of  self, psychiatric morbidity and quality of  life in cancer patients.   
        Various definitions of coping are given in the literature which are as 
given below: 
1.  Adapting to a situation that is demanding (Rowland, 1989) 
2.  Defense mechanisms that are stable and generalised (Valliant, 
1977) 
3. Cognition or emotion related intrapsychic efforts or field related 
action may be applied to eliminate or decrease of annihilate the 
present or future expected stresses.  
          Various methods of coping have been described in literature and 
they are: 
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1.  Emotional coping (Weismann, 1994) 
2. Coping with social support  (Dunkel et al,1994) 
3. Coping through reconstructive surgery  (Anderson and Kaezonesk, 
1996).   
  McCaul et al (1999) proposed the mechanism of avoidant coping to be 
the most consistent predictor of distress in breast cancer patients.    
     
QUALITY OF LIFE(QOL); 
         With the advancement of treatment modalities and diagnostic 
techniques, survival rate of breast cancer has increased,  but has it been 
the same with Quality Of Life? This is an ongoing debate because the 
treatment itself results in psychological distress, disturbances in concept 
of self and physical functions leading to impairment in QOL. (Bhatty et 
al 2004, Vinokur et al, 1990, Levy et al, 1992. 
        The instruments used to assess QOL are  -   Functional Living 
Index for Cancer, RSCL, CARES- SF, EORTC-QOL, Health Related 
Quality Of Life. 
       An Assessment of QOL in breast cancer patients using EORTC-
QOL C30/+BR 23 questionnaire. (Saleha et al, 2010) reveal that; 
 1,  The primary goal of cancer treatment is improvement of quality life. 
(Lesley 1995). 
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2.   Anxiety and depression along with impaired physical and sexual 
functioning followed treatment with surgery. (Raneker et al, 1952 ,  Bard 
et al , 1955) 
Studies on psychological outcome in women with benign or 
malignant disease showed that problems with self-esteem, body image 
and psychiatric morbidity were imminent in post mastectomised women. 
(Morris et al, , 1978, Maguire et al, 1978). 
 HRQOL should be framed as a multidimensional construct.  
Important domains of the QOL include physical functioning; social 
interaction, physiological well being and disease symptoms or treatment. 
  Describing QOL as the basis of individual therapeutic modality will 
be useful from patient’s perspective (Winer, 1994).  Measuring QOL is 
important in evaluating treatment outcome and could be of prognostic 
significance for the planning of effective intervention. 
   Bloom et al (1987) reported that women who underwent 
mastectomy experience more  social and psychological distress which 
can lead to disruption of her daily living for over a year after treatment. 
Impairment with QOL was higher for women with stage II breast cancer 
who underwent adjuvant treatment following surgery. 
  Marguire et al (1978) reported greater impairment of QOL  in 
radiotherapy  patients mainly due to physical changes.  Marguire  et al, 
(1980) reported increased psycho emotional morbidity in patients who 
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were  given Chemotherapy.  Cooper et al (1979) suggested that it could 
be due to the effect of chemotherapy regimen Cyclophosphamide, 
Methotrexate and5 - Flurouracil that was previously used widely.  The 
authors end with a question asking what would be the state if traditional 
end points favour a particular treatment method but QOL suggests a 
different one to be superior?  Though the dilemma persists, it should be 
reasonable to use QOL as endpoint if symptom palliation is desired to be 
achieved.    
  It is the responsibility of treating physician to take into account 
individual preferences  if there is a possibility and to provide  psycho 
education to the patients.     
Ganz et al 1990, in his study noted that emotional well being in cancer 
survivors was important in predicting sexual dysfunction.    Bellino et al, 
2010 assessed the effects of personality characteristics on QOL, in 
patients who underwent breast reconstruction after mastectomy.  
Significant correlation was found between personality dimension and 
interpersonal functioning on QOL.  Patients with high harm avoidance 
were apprehensive and   doubtful.  In these patients, body image 
restoration produced significant reduction, insecurity and social anxiety.  
For, vindictive/self centered patients consider reparative process as a 
fulfillment of their desire to revenge on cancer.  The study concluded by 
suggesting to include preoperative personality assessment in patients 
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undergoing BCT to identify predictive factors for better outcome and 
QOL after early intervention. 
 Chen et al, 2010 in a systematic review highlighted the need for more 
validated patient reported outcome measures for future research.  They 
also emphasized the need to develop cancer specific and    treatment 
specific measures to  assess QOL and body image disturbances.   
  In a review article by Montazesil, 2008, published articles from 1964 
to 2007 were included.  It was found that the most common and 
important disease and treatment related side effects were the ones 
neglected mainly in research and clinical practice.  They include arm 
morbidity, pain, fatigue and post menopausal symptoms. 
 Cognitive functions, body image and menopausal symptoms should 
be given priority apart from long term effects of newer therapy which 
include musculoskeletal and neurological side effects (Grinison et al, 
2007). 
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HYSTERECTOMY 
 Most of the available literature are on hysterectomies performed for 
benign reasons and  only a few studies are  available for malignant 
reasons.  So the psychological studies conducted on hysterectomies for 
benign reasons cannot be extrapolated to malignant conditions since the 
risk factors and prognosis are entirely different for both the conditions.  
Since loss of reproductive system has a major impact on women’s 
psychology, it is essential to monitor the psychological behavior both pre 
and post operatively.  Post operative care and studies by the obstetricians 
mainly focus on the physical aspects and the psychological aspects which 
are of profound importance for the wellbeing and quality of life of these 
patients are mostly neglected. (Mathews et al, 1992).  Copper et al (1981) 
opine that    the  post hysterectomy psychological behavior cannot be 
attributed to hormonal changes alone. It has been reported by Gath et al 
(1980) that psychological disturbances prior to hysterectomy shows 4-5 
times higher incidence than in the normal population.  As for as the post 
operative psychological problems are concerned,  the preoperative 
morbidity and the surgery itself have an impact on them (Ryan et al, 
1989). 
 Kincey et al (1984) enumerate three sets of psychological problems 
in hysterectomy patients as seen in the literature.  They are, 
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a)  Anxiety and depression due the surgical procedure 
b) Sexual dysfunctions such as pain, post operative sexual activity, 
libido etc 
c) Reactions concerning to self concept,especially, self-esteem changes, 
perception of femininity etc, Of course, these parameters are 
considered to be the most ambiguous.       
Polius (1974) showed that loss of reproductive organs and capacity, 
fear of aging, and decreased sexuality lead to emotional crisis which 
ultimately results in depression in these patients. 
Kraft Ebing in 1890 has reported the hysterectomy was the cause of 
psychoses more frequently than any other surgical procedure.  
Subramanian and Subramanian (1982) also reported that hysterectomy 
patients showed more frequent psychiatric disturbances than patients 
undergoing any other gynecological surgeries. 
 “Post hysterectomy syndrome” was proposed by Richard in 1974 
which includes mood depressions, fatigue, headaches, insomnia, hot 
flushes, dizziness along with urinary symptoms. 
  A “stress response syndrome” following hysterectomy  was proposed 
by Kaltreider and Wallance in 1979 which they described as a reaction to 
the loss of child bearing capacity.On the contrary to earlier studies in the 
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period from 1977 to 1989 four prospective studies conducted showed that 
post hysterectomy women seldom have psychiatric disturbances.              
Bilateral oophorectomy together with hysterectomy leading to 
surgical menopause should be handled by gynecologists in a more serious 
manner and they should patiently explain all the issues in connection 
with menopause and hysterectomy to the patients and simply prescribing 
iron tablets and diet supplements in those situations will not be sufficient 
as per Baldaro et al 2003. 
Hartmann et al 2004 reported that patients who had preoperative 
pelvic pain not only had higher level of anxiety before surgery but also 
showed more concern about the outcome of hysterectomy.    According 
to Macdonald et al 1999, women undergoing hysterectomy expressed 
anxiety and depression also as body complaints.  They showed decreased 
level of social well being even after 24 weeks of surgery.   
 Kjeruff et al (2002) assessed that while planning hysterectomies for 
benign conditions the physical, psychological and spiritual domains have 
to be taken into consideration prior to deciding upon the surgery.  The 
surgery which was taken as a last resort predisposed these patients to 
anxiety and depression resulting from negative cultural and male attitude. 
As per Hamilton et al 1959, relevant  psychotherapy in necessary dose 
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and duration should be given   for the response in both depression and 
anxiety. 
 Many women view hysterectomy as a stressful event as reported by 
Cohen et al (1989).  The usual complications are bladder dysfunction and 
morbidity due to fever and thromboembolic disease. A longitudinal study 
conducted by them showed that these complications can be reduced by 
using prophylactic antibiotics, modern surgical techniques, and early 
ambulation. But apart from these physical complications, the 
psychological problems  such as depression, anxiety, sexual dysfunctions 
and lower self-esteem also have to be given due attention and care. 
(Cohen et al 1989 and Meikie Brody and Pysh 1977.) 
 Lindmann in 1941 reported the rate of depression in women 
following hysterectomy to be 40% which was further corroborated by 
Melody in 1962.  Roopnarinesingh and Gopeesingh (1982) in their 
Trinidadian study reported that depression is the major complication 
occurring in 38% of women following  mastectomy.   
 But more recent studies, do not support the incidence  of depression in 
these patients  as reported in the earlier studies.  Khastgir et al (2000) in 
his review showed that adverse psychological problems in post 
hysterectomy women are not directly the result of the surgical procedure. 
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  More recent works by Carlson et al (1994), Ferroni and Deeble 
(19960, Lambden et al (1997), Ryan (19970 and Rannestad et al. (2001) 
depicted that as the gynecological symptoms and the hormone levels 
improve, the psychological symptoms also improve in most of the 
women.  In fact positive outcomes including decreased Drummond and 
Field (1984) depression was noted in recent works.      
 It is generally accepted that any surgical procedure would invoke fear 
and anxiety in the patients,  But many studies conducted on post surgical 
scenario, have emphasized on depression more than anxiety following 
hysterectomy. (Roopanarinesingh and Gopeesingh, 1982).  Of course, 
more recent research do not support the reports about the incidence of 
depression.  Carter (1981) studied the influence of preoperative anxiety 
on the post operative conditions.    
  Ryan et al (1989) showed that the depressed mood before 
hysterectomy was 16 – 58% which was higher when compared to that 
after the surgery which was 8 to 32%.  They suggested that the post 
operative outcome probably reflected the psychological adjustment made 
by the patients prior to the surgery. The specific personality constrains or 
individual attributes which may lead to negative  psychological problems  
before or after the surgery are not well defined yet.  Northorst-Boor and 
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von Schoultz (1992) showed neuroticism in women may lead to  
increased levels of depression after the surgery.  While Singh et al (1983) 
showed with the higher preoperative expectations, the postoperative 
depression levels were also high. 
 Henducks-Mathews (1991) suggested that the sexual abuse that the 
patient experienced  preoperatively may also result in postoperative 
negative psychological complications. According to him it is essential for 
preoperative assessment and counselling when required   particularly 
about the surgery and also the sexual abuse in the past. 
 Premature menopause and loss of ovaries as a result of hysterectomy 
has been shown to be responsible for incomplete remission of depression 
following the surgery.  (Melzack, 1982).  He has shown that ovarian 
failure increased the risk of depression.  Khast and Studd (1998) reported 
through controlled clinical trials that after hysterectomy the estrogen 
enhanced mood and improved the scores of depression. 
  Positive influence to negative impact has been shown to result from 
the effect of surgery on sexuality.   Gath et al (1982) in a study consisting 
of 156 women could not find any decrease in sexuality after 
hysterectomy.  But Clarke et al (1995) showed that though there was no 
change in the frequency of sexual acts, there was a change in the sexual 
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desire postoperatively. Several studies differ in their inferences 
associating sexual desire and hysterectomy.  The differences are mainly 
because of the differences in defining the sexual desire, ,methods used 
for its assessment and also the type of surgery. (Galyes. 1999).   Fermi 
(1994) proposed that women undergoing hysterectomy for malignant 
conditions show different psychological behaviour than those for benign 
conditions. 
 Sexuality may be affected by the type of surgery performed as 
proposed by Stockman, (1995).  The scar left by  hysterectomy could also 
affect body image and hence sexuality also.(Bernhard,1992). On the 
contrary, Gayles et al, (1999) could not find dependence on the type of 
surgery and sexuality. They observed that the behaviour of the partner 
influenced the sexual desire of the women greatly.  Hence it is concluded 
that further research is essential in this respect.    
 Bernhard (1992) reported that the sexual partners of these women 
have less understanding about the surgical aspects and its effects on 
sexual activity.  He proposed that there is a necessity to change the 
attitude and beliefs of the men as well as the community in this aspect.  
Stockman (1995) formulated the screening to be done for these patients 
preoperatively to identify the potential high risk factors.  They are 
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multiple previous surgeries, history of or current psychiatric disorders, 
chronic pelvic pain and multiple indicators for the surgery. 
Hamilton (1999) discussing the various physiological effects of 
hysterectomy, explained that the decrease in estrogen levels caused by 
the surgery leads to atrophic vaginitis resulting in sexual difficulties 
including dyspareunia.  (Thranov and Klee, 1994).  According to Lalos 
and Lalos (1996)  hysterectomy develops vasomotor symptoms which 
may increase the rate of incontinence.  This condition is highly 
distressing and embarrassing and may result in adverse effects on sexual 
functioning.    
 Kew et al (2002) feels that information regarding psychosexual 
morbidity in endometrial and ovarian cancer patients is lacking..  Many 
studies are focused on cervical cancer and then  on pre invasive and 
invasive vulvar lesions.   
 Apart from the actual surgical procedure, the adjuvant therapies 
offered for gynecological malignancies also have an impact on physical 
and psychological aspects of the patient who experience secondary 
trauma due to the therapies. 
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 The side effects of chemotherapy like nausea, vomiting, constipation, 
altered sense of taste and smell, mucositis, diarrhea and weight 
alterations decrease the desire for as well as the frequency of sexual 
actions.   Apart from these, alopecia and loss of pubic hair also lead to 
uncomfortable and distressing feelings and reduced interest in sexuality. 
(Shover,1997).  According to Spence (1997) these also cause 
psychological morbidity.   
 Pelvic radiotherapy irritates the intestinal lining which results in 
changes in bowel habits and a feeling of fatigue. These factors invariably 
lead to reduced sexuality and loss in libido. (Auchincloss, 1991).  Both 
external beam radiotherapy and implants cause physiological changes in 
women.  These resulting in vaginal epithelial damage finally lead to 
vascular fibrosis and stenosis.  Sexual dysfunction, dyspareunia, pain 
during examination of the pelvis, gonadal toxicity and finally infertility 
are listed as the long term complications of these therapeutic modalities.     
Coping and Self-esteem: 
 Drummond and Field (1984) reported that hysterectomy lowers self 
esteem particularly in those patients who have depression. Webb et al  
(1986  ) stressed the need for social support in these patients which plays 
an important role in coping.  Cabson (2010) reported that after 
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hysterectomies which were performed for benign reasons the women 
showed increased socialization.  He attributed this finding to more energy 
and an increased urge the women acquire for contacting friends and 
relatives after the surgery when their symptoms are alleviated.  Ferroni 
and Drebe (1996) emphasized the need for positive support by the 
husbands.  He mentioned that this support leads to restarting their sex 
lives earlier than those who  do not receive such a support. 
 After hysterectomy, the loss of the uterus has been shown to decrease 
sexual pleasure and interest.  According to Dinnerstein et al (1977) 37% 
of the women after hysterectomy showed decreased interest in sexual 
relationships.  In contrary, Humphries (1980) reported that no change 
was felt by many womenCooper et al (1978) measured psychosocial 
variables at four points of time in the first year following hysterectomy 
performed for benign reasons.  He estimated that anxiety, depression and 
hostility did not vary significantly at all four times measured.  Self 
esteem scores showed values of 0 to 75 where negative impact is 
depicted by the high scores.   Though gynecological cancers have been 
reported to be the second most common cancers in women, psychological 
studies on these patients are lacking.   
 
35 
 
Quality of Life: 
 Jawor et al in 2001 reported lowered self esteem and changes in QOL 
in patients undergoing hysterectomy.   
       Carter et al (2010) studied the emotional, sexual and quality of life of 
hysterectomy patients who underwent the surgery for early stage cervical 
cancer. He reported that quality of life, mood, distress, and sexual 
functioning did not change significantly with the type of surgery 
performed 
SEXUAL DYSFUNCTION 
The sexual response after oophorectomy and hysterectomy was 
studied by Dennerstein and Wood in 1997 who reported that one third of 
the patients showed deterioration of sexual dysfunctioning. Vincent et al 
(1975) reported 29%    and 33% of radiation and hysterectomy patients 
respectively reported sexual difficulties. 
      
SEXUAL FUNCTIONING AMONG BREAST CA,NCER 
GYNECOLOGICAL CANCER AND HEALTHY WOMEN    
Silverberg (1984) reported that breast and gynecological cancer 
women are at a high risk for sexual problems.  These two sites combined 
form 44% of female cancers diagnosed in a year.  Extensive studies have 
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been conducted on psychological outcomes in breast cancer patients.  
Most of these studies have estimated the overall sexual disruption, 
decreased intercourse frequency, difficulties with orgasm from 21% to 
39% in  retrospective manner.  (Silberfarb et al, 1980).  Though 
gynecological cancers have been reported to the second most common 
cancers in women, psychological studies on these patients are lacking.   
Vincent et al (1975) reported 29%    and 33% of radiation and 
hysterectomy patients respectively reported sexual difficulties. Body 
image and marital adjustment are relevant areas common for both breast 
and gynecological cancer patients.  Hysterectomy or pelvic irradiation 
may not result in body image changes but disruption in body image and 
quality of life are noted in hysterectomy patients also. (Daly,1978, 
Roeske, 1978) 
Both physical and physiological mechanisms are affected negatively.  
Maas et al (2002) elaborated the genital problems in gynecological 
cancer patients after hysterectomy which includes, difficulties in 
lubrication, decrease in elasticity and length of vagina and absence of 
genital swelling.    
 Shover et al (1989) and Wejmer et al (1991) reported that adjuvant 
therapy offered postoperatively also results in sexual dysfunctions.      
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 In the restrospective analysis it has been found that diminshed or 
competely disrupted sexuality ranged from 6 mto 19 % in patients 
undergoing radical hysterectomy and from 44% to 79% for the patients 
receiving radiotherapy as well.  They are the first to indicate that there is 
specific pattern of sexual difficulties in patients diagnosed to have cancer 
and offered radical gynecologic treatment.  They suggest that sexual 
activity including intercourse may be maintained after vaginal 
reconstruction in these patients but other sexual difficulties remain.  
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                        AIM & OBJECTIVES 
 
AIM OF THE STUDY 
          To assess the disturbances in body image, psychiatric morbidity 
and their effects on the quality of life in post–mastectomy breast cancer 
patients and compare the above variables with  post–hysterectomy 
uterine cancer patients.  
OBJECTIVES: 
1. To assess and compare the disturbances in body image and concept 
of self in post-mastectomy  and post-hysterectomy  patients. 
2. To assess and compare the presence and nature of psychiatric 
morbidity in both the groups. 
3. To assess and compare the quality of life in both the groups. 
4. To assess the possible correlation between body image 
disturbances, psychiatric morbidity and the quality of life in both 
the groups. 
5. To assess the possible correlation between socio demographic data 
and clinical characteristics of the primary illness and the above 
mentioned variables (Quality of life, Body image disturbances and 
Psychiatric morbidity) in both the groups. 
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NULL HYPOTHESES 
1. There is no significant difference in the disturbance in body 
image and concept of self between the study and control 
groups. 
2. There is no significant difference in psychiatric morbidity 
between  the groups. 
3. There is no significant difference in the quality of life between 
the groups. 
4.  There is no significant relation between body image 
disturbances, psychiatric morbidity and quality of life in both 
the groups. 
5. There is no significant relation between socio demographic 
profile,  clinical characteristic and body image disturbances, 
psychiatric morbidity and quality of life in both the groups. 
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MATERIALS AND METHODS 
               This is an Observational Cross Sectional study conducted at 
Rajiv Gandhi Government General Hospital, Chennai and the Institute of 
Obstetrics and Gynaecology, Chennai. The study was approved by the 
Institutional Ethical Committee. It  was conducted over a period of four 
months from August 2012 to November 2012. Subjects included two 
groups of patients attending  the out patient and inpatient departments of 
medical, surgical and radiation oncology at Rajiv Gandhi Government 
General Hospital, Chennai and the department of Gynaecology at the 
Institute of Obstetrics and Gynaecology, Chennai. The first group 
included patients who had underwent mastectomy for breast malignancyy 
and the second group encompasses patients who had underwent 
hysterectomy for gynaecological malignancies. Subjects were selected 
based on the following inclusion and exclusion criteria. 
INCLUSION CRITERIA: 
1. Age : 35 – 65 years 
2. Duration of 3 months to 1 year after the surgical procedure 
3. Subjects who are willing and able to give consent 
  EXCLUSION CRITERIA: 
1. H/O tumour recurrence or metastasis 
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2. H/O other medical, surgical or neurological illnesses. 
3. H/O mental retardation  
4. H/O previous psychiatric illnesses  
                   After explaining the nature of the study, informed consent was 
obtained from the subjects. Both the subjects and the care givers were 
interviewed. Details of socio demographic profile and clinical features 
of the illness were obtained. Detailed history including past, personal 
and family history of psychiatric illness, malignancies was obtained. 
After general physical and  systemic examination, a detailed mental 
status examination was done and the following scales were 
administered to both the groups. 
                     52 patients who had underwent mastectomy were selected 
and among them, 40 were included in the study due to the following 
reasons: 5 had co morbid medical illness,  4 had metastasis , 1 had 
recurrence and 2 were not willing to give consent. 50 patients who had 
underwent hysterectomy were selected as the second group and among 
them, 40 were included in the study since 4 had co morbid medical 
illness, 3 had metastasis, 2 had previous history of psychiatric illness 
and 1 did not give consent. The following tools were administered. 
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TOOLS EMPLOYED : 
1. Proforma for socio demographic data and clinical characteristics 
2. MINI PLUS  
3. Hamilton rating Scale for Depression – HAM D 
4. Hamilton rating Scale for Anxiety – HAM A 
5. European Organisation for Research and treatment Centre 
(EORTC) – Quality of Life Questionnaire – 30(QLQC - 30),  
Breast module – 23(BR 23),  Endometrium module – 24(EN 24). 
6. Multidimensional Body Self-Relations Questionnaire (Abbreviated 
Scale)(MBSRQ - AS) 
7. Body Image Scale (BIS) 
 
PROFORMA FOR SOCIO DEMOGRAPHIC DATA AND 
CLINICAL CHARACTERISTICS: 
           It includes – name, age, education, occupation, socioeconomic 
status, religion, address, marital status, family type, no of children, 
duration of illness, diagnosis, staging, complications of the disease, 
treatment modalities and complications,  drug compliance,  psychological 
reactions. Past h/o mental illness,  medical illness and treatment,  suicidal 
attempts, menstrual h/o, marital h/o, substance abuse, family h/o 
psychiatric illness and malignancies.  
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MINI PLUS (MINI INTERNATIONAL NEUROPSYCHIATRIC 
INTERVIEW ): 
It was developed as a brief structured interview for major Axis I 
psychiatric disorders based on DSM IV and ICD 10. Validation and 
Reliability studies done comparing MINI to SCID – P for DSM – IV and 
CIDI developed by WHO show high validity and reliability scores. It 
requires a shorter duration of time(15 mins) compared to other scales. 
The M.I.N.I. Plus is divided into modules identified by letters, each 
corresponding to a diagnostic category.  The clinician should be sure that 
each dimension of the question is taken into account by the patient (for 
example, time frame, frequency, severity, and/or alternatives).  
Symptoms better accounted for by an organic cause or by the use 
of alcohol or drugs should not be coded positive in the M.I.N.I.  The 
M.I.N.I. Plus has questions that investigate these issues  
HAMILTON RATING SCALE FOR DEPRESSION : 
             This is a widely used scale, developed by Dr. Max Hamilton to 
assess the symptoms of depression before , during and after treatment.. 
This is an observer rated scale consisting of 17 to 21 items. The items are 
either rated from 0 (none/absent) to 4 (most severe) or from 0 
(none/absent) to 2 (severe) based on the items. Ratings are made on the 
basis of clinical interview and from any available information from the 
nursing staff or family members. It lays emphasis on the somatic 
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symptoms and it is more suitable for severe illness.it also depends on the 
clinical acumen of the rater. Excellent validation base and the ease of 
administration are the strengths of this scale. Inter rater reliability is 0.87 
to 0.95. Severity of depression is scored as follows :  
0 to 7 – normal 
8 to 13 – mild 
14 to 18 – moderate 
19 to 22 – severe 
>=23 – very severe 
HAMILTON RATING SCALE FOR ANXIETY : 
This scale developed by M. Hamilton, is one of the most widely 
used scales for anxiety. It consists of 14 items. Each item is rated on a 
scale from 0 (not present) to 4 (severe). It mainly focuses on the somatic 
symptoms than psychic symptoms, relying mainly on patient’s subjective 
perspective. This scale is mainly used to assess the course of the 
symptoms and the response to treatment. This is a brief scale, easy to 
administer and widely accepted. These form the strengths of this scale. 
Limitations include excessive focus on somatic symptoms alone than 
other symptoms of anxiety ; relying on patient’s subjective experience 
excessively and lack of generalisation.  
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Severity is scored as follows: 
<17 – mild 
18- 24 – mild to moderate 
25 – 30 – moderate to severe 
>= 31 – very severe 
EUROPEAN ORGANISATION FOR RESEARCH AND 
TREATMENT CENTRE–QUALITY OF LIFE QUESTIONNAIRE: 
EORTC QLQ C30 consists of 30 items including five functional scales 
(physical, role, emotional, social and cognitive) and nine symptom scales 
with one global health scale. The supplementary modules BR23 and EN 
24 consists of 23 and 24 items respectively for breast and gynaecological 
malignancies. After getting information from the subjects, raw scores are 
calculated and then transferred to 0 – 100 scales. Higher score on any 
subscale indicates higher level of functioning. In case of symptom scales, 
the higher scores imply higher level of symptoms which indicate worse 
quality of life. It is an Internationally validated scale for worldwide 
usage.                    
BODY IMAGE SCALE: 
It is a 10 item scale developed by EORTC group to assess body 
image in cancer patients. Validation of this scale was done by Hopwood 
et al in 2000. The 10 test items comprise “affective items (e.g. feeling 
feminine, feeling attractive), behavioural items, (e.g. find it hard to look 
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at self naked, avoid people because of appearance), and cognitive items 
(e.g. satisfied with appearance, or with scar)”.                   
The four options for rating body image changes were selected to be 
consistent with current QL measures, namely ``not at all'' (score 0), ``a 
little'' (score 1), ``quite a bit'' (score 2) and ``very much'' (score 3). The 10 
item scores were then summed to produce overall summary score for 
each patient, ranging from 0 to 30. Zero scores represented no 
symptom/distress and higher scores represented increasing 
symptoms/distress. This is a self reported questionnaire.  
 
MULTIDIMENSIONAL BODY SELF RELATIONS 
QUESTIONNAIRE 
The Multidimensional Body-Self Relations Questionnaire 
(MBSRQ) is a 69-item self-report inventory for the assessment of self-
attitudinal aspects of the body-image construct. An initial version of this 
instrument in 1983 contained 294 items and was termed the BSRQ. 
Subsequent versions eliminated or replaced items on the basis of 
rational/conceptual and psychometric criteria. The MBSRQ is intended 
for use with adults and adolescents (15 years or older). The instrument is 
not appropriate for children. Most body-image researchers are principally 
interested in the appearance related subscales of the MBSRQ and wish to 
administer a shorter questionnaire that excludes the fitness and health 
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items. Accordingly, they may elect to use the 34-item MBSRQ-AS 
(MBSRQ-Appearance Scales) version of the instrument. The MBSRQ-
AS includes the following subscales: “Appearance Evaluation, 
Appearance Orientation, Overweight Preoccupation, Self-Classified 
Weight, and the Body Area Satisfaction Scale. “The scale is rated from 0 
to 100. Higher scores indicate better body image appraisal. 
           
 
 
 
 
 
 
 
 
 
 
  
48 
 
DATA ANALYSIS AND RESULTS 
STATISTICAL ANALYSIS: 
 Comparison of  socio demographic data of post mastectomy and 
post hysterectomy  groups : Chi square test 
 Comparison of Body Image Disturbances, Psychiatric Morbidity 
and Quality of Life among both the groups ; Mann-Whitney U test 
 To assess the relation between socio demographic profile, clinical 
correlates and of Body Image Disturbances, Psychiatric Morbidity 
and Quality of Life in both the groups : Spearman’s correlation. 
 To assess the relation between body image disturbances,  
psychiatric morbidity and quality of life among both the groups.: 
Spearman’s correlation 
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Table : 1  Frequency distribution of socio  
demographic data in both Groups 
 
 
POST MASTECTOMY 
PTS 
POST 
HYSTERECTOMY 
PTS 
N Percent N percent 
AGE: 35-45 
45-55 
55-65 
13 
14 
13 
32.5 
35.0 
32.5 
11 
15 
14 
27.5 
37.5 
35.0 
EDUCATION:illiterate 
Primary 
SSLC 
HSC 
14 
18 
6 
2 
35.0 
45.0 
15.0 
5.0 
15 
20 
5 
0 
37.5 
50.0 
12.5 
0 
OCCUPATION:unemploye
d 
Nonprofessional 
18 
22 
45.0 
55.0 
22 
18 
55.0 
45.0 
SES:LSES 
MSES 
29 
11 
72.5 
27.5 
27 
13 
67.5 
32.5 
MARITAL 
STATUS:unmarried 
Married 
Separated 
Widowed 
4 
25 
1 
10 
10.0 
62.5 
2.5 
25.0 
6 
24 
1 
9 
15.0 
60.0 
2.5 
22.5 
RESIDENCE: rural  
Semiurban 
Urban 
14 
16 
10 
35.0 
40.0 
25.0 
16 
14 
10 
40.0 
35.0 
25.0 
RELIGION:Hinduism 
Islam 
Christianity 
 
24 
6 
10 
60.0 
15.0 
25.0 
25 
7 
8 
62.5 
17.5 
20.0 
PARITY: nulliparous 
Parous-1-2 
≥3 
9 
22 
9 
22.5 
55.0 
22.5 
8 
24 
8 
20.0 
60.0 
20.0 
 
      In both the groups, the mean age group was 50 years (45-55 years). 
35.0% and   37.5% belonged to this age group in post-mastectomy and 
post-hysterectomy groups respectively.  Majority of them belonged to 
low socioeconomic status (Mastectomy n-29, 72.5%; Hysterectomy n-27, 
67.5%).  62.5% (n=25) in mastectomy group and 60% (n=24) in 
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hysterectomy group were married and living with their husbands.  
Majority of them were Hindus (n=24; 60% in group 1 and n=25; 62.5% 
in group 2).  9 of women (22.5%0 in mastectomy group and 8 (20%) in 
hysterectomy group were nulliparous.     
 
Table : 2    Comparison of socio demographic data among the groups 
 
POST 
MASTECTOMY 
PTS 
POST 
HYSTRECTOM
Y PTS 
CHI SQUARE 
N N 
AGE: 35-45 
45-55 
55-65 
13 
14 
13 
11 
15 
14 
0.888 
EDUCATION:illiterate 
Primary 
SSLC 
HSC 
14 
18 
6 
2 
15 
20 
5 
0 
0.526 
OCCUPATION: 
unemployed 
nonprofessional 
18 
22 
22 
18 0.371 
SES:LSES 
MSES 
29 
11 
27 
13 0.626 
MARITAL 
STATUS:unmarried 
Married 
Separated 
Widow 
4 
25 
1 
10 
6 
24 
1 
9 
0.925 
RESIDENCE: rural  
Semiurban 
Urban 
14 
16 
10 
16 
14 
10 
0.875 
RELIGION:Hinduism 
Islam 
Christianity 
 
24 
6 
10 
25 
7 
8 
0.852 
PARITY: nulliparous 
Parous-1-2 
≥3 
9 
22 
9 
8 
24 
8 
0.903 
No significance seen in chi square testing 
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Comparison between the two groups on age, education, occupation, 
address, socioeconomic status, religion and parity showed no significant 
difference between the groups, thereby showing the groups are 
comparable on these parameters.  
Table :3  Frequency of illness correlates in  
post mastectomy group 
 
POST MASTECTOMY PTS 
N Percent 
Duration since surgery: 3-
6m 
6-12m 
20 
20 
50 
50 
Diagnosis: lobular 
Infiltrating lobular 
Ductal 
Infiltrating ductal 
10 
4 
21 
5 
25.0 
10.0 
52.5 
12.5 
Stage: I 
II 
III 
5 
19 
16 
12.5 
47.5 
40.0 
Treatment: surgery+CT 
surgery+CT+RT 
sugery+RT 
sugery+CT+tamoxifen 
13 
13 
1 
13 
32.5 
32.5 
2.5 
32.5 
Neoadjuvant CT: yes 
No 
19 
21 
47.5 
52.5 
 
     50% (n=20) of patients were assessed in 3-6 months after 
mastectomy and in 6-12 months after hysterectomy. The most common 
histological type of breast cancer operated belonged to ‘Ductal 
carcinoma’ (n=21; 52.5%).  The common stage of the disease was Stage 
II (n=19; 47.5%).  13 patients (32.5%) received surgery (Modified radical 
mastectomy) + chemotherapy. The same number of patients received 
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Surgery with chemo and radiotherapies and Surgery with chemotherapy 
and tamoxifen therapy.  One woman received surgery and post 
radiotherapy.  Neoadjuvant chemotherapy was given to 19 patients 
(47.5%).    
 
Table: 4   Frequency of illness correlates in post hysterectomy group 
 
 
POST HYSTRECTOMY PTS 
N percent 
Duration since surgery: 3-
6m 
6-12m 
22 
18 
55.0 
45.0 
Diagnosis: cervical 
Endometrial 
20 
20 
50.0 
50.0 
 
Stage: Ia 
Ib 
Ic 
IIa 
IIb 
17 
7 
4 
10 
2 
42.5 
17.5 
10.0 
25.0 
5.0 
Treatment:  
                  TAH + BSO 
              TAH+BSO+RT 
              TAH + BSO + CT 
5 
30 
5 
12.5 
75.0 
12.5 
Neoadjuvant RT: yes 
No 
14 
26 
35.0 
65.0 
 
    22 patients (55%) were assessed in a period of 3-6 months post 
operatively and 18 persons (45%) within 6-12 months.  50% (n=20) each 
were diagnosed with cervical and endometrial cancers.  Majority of them 
were in Stage Ia (n=17; 42.5%).  All patients underwent Total Abdominal 
Hysterectomy (TAH) with bilateral salpingo-oophorectomy. Post 
operative radiotherapy was given to 30 patients (75%) and 5 patients 
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(12.5%) received adjuvant chemotherapy.  Neoadjuvant radiotherapy was 
given to 14 patients. 935.0%)   
 
Table : 5      Frequency of clinical correlates in both groups 
 
POST MASTECTOMY 
PTS 
POST 
HYSTRECTOMY PTS 
N Percent N Percent 
PERCEPTION: positive 
Negative 
Neutral 
10 
17 
13 
25.0 
42.5 
32.5 
15 
16 
9 
37.5 
40.0 
22.5 
FAMILY H/o : 
psych illness 
alcohol abuse 
nil 
13 
10 
17 
32.5 
25.0 
42.5 
15 
9 
16 
37.5 
22.5 
40.0 
FAMILY H/O 
MALIGNANCY: yes 
No 
11 
29 
27.5 
72.5 
15 
25 
37.5 
62.5 
MENOPAUSE: yes  
No 
23 
17 
57.5 
42.5 
27 
13 
62.5 
37.5 
SUBSTANCE ABUSE: yes 
No 
4 
36 
10.0 
90.0 
5 
35 
12.5 
87.5 
SEXUAL DYSFUNCTION: 
yes 
No 
Not active 
15 
9 
16 
37.5 
22.5 
40.0 
17 
8 
15 
42.5 
20.0 
37.5 
 
      Perception and attitude towards illness:  Majority of them, n=17,  
(42.5%) and n=16 (40.0%) in groups 1 and 2 respectively had negative 
attitudes towards the disease and prognosis. 
      Family history of  mental illness including alcohol abuse was present 
in 32.5% (n=13) in the mastectomy group and 22.5% (n=9) in the 
hysterectomy group. 
     Family history of breast or gynecological malignancy was noted in 
27.5% (n=11) of group e and 37.5% (n=15) of group 2 patients.  57.5% 
(n=23) in group 1 and 62.5% (n=27) in group 2 attained menopause.   
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    37.5% (n=15) in the mastectomy group and 42.5% (n=17) in the 
hysterectomy group experienced sexual dysfunction.  40% (n=16) in 
group 1 and 37.5% (n=15) in group 2 were not sexually active.     
 
Table : 6  Comparison of quality of life in both groups 
 
 Functional scale 1 Symptom scale 1 Global health status 
 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 
 
Mean 
Median 
Standard Deviation  
 
372.12 
383.10 
   41.35 
 
342.46 
341.80 
   44.37 
 
208.89 
208.70 
    66.23 
 
    221.96 
200.00 
    73.82 
 
49.55 
50.00 
13.37 
 
46.07 
    50.00 
    13.21 
Mann-Whitney U 524.500 718.500 692.000 
Wilcoxon W 1344.500 1538.500 1512.000 
Z -2.652 -.785 -1.079 
Asymp. Sig. (2-tailed) .008** .433 .281 
a. Grouping Variable: Cancer     *p <0.05 **p <0.01 
 
 
Comparison of quality of life between the two groups showed 
significant difference in functional scale -1(p <0.01), implying  post 
hysterectomy patients had lesser scores on functional scales on the whole and 
thus decreased functioning in all domains – physical, emotional, social, cognitive 
and role functions.   
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Table : 7  Comparison of psychiatric morbidity and body image    
disturbances in both the groups 
              
 HAM D HAM A BIS 
 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 
 
Mean 
Median 
 Std Deviation 
 
11.48 
11.00 
5.97 
 
 
12.95 
12.50 
4.99 
 
 
8.68 
8.00 
4.27 
 
 
9.25 
8.00 
3.56 
 
 
9.90 
10.00 
4.76 
 
 
7.98 
7.00 
3.35 
 
Mann-Whitney 
U 
 
634.000 
 
704.500 
 
568.000 
Wilcoxon W 1454.000 1524.500 1388.000 
Z               -1.602 -.925 -2.246 
Asymp. Sig. (2-
tailed) 
.109 .355 .025* 
a. Grouping Variable: Cancer                  *p <0.05 **p <0.01 
 
Comparison of depression, anxiety and body image disturbances 
among the two groups showed   significant difference in body image 
disturbance between the groups but no difference in  anxiety and 
depression scales. The scores on body image disturbances were lower in 
post mastectomy patients and reached significant levels. (p < 0.05). 
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Table : 8  Comparison of multi dimensional  
body image in both groups 
 Mastectomy 
mean 
Mastectomy 
median 
Mastectomy 
S.D 
Hysterectomy 
mean 
Hysterectomy 
median 
Hysterectomy 
S.D 
AE 2.57 2.71 0.67 2.35 2.28 0.56 
AO 2.11 2.00 0.48 2.47 2.21 0.71 
BASS 2.93 2.78 0.34 2.72 2.78 0.41 
OWP 1.92 1.75 0.61 2.69 3.00 0.63 
SCW 3.07 3.00 0.91 3.51 3.50 0.61 
 
 AE AO BASS OWP SCW 
 
Mann – Whitney U 
Wilcoxon W 
       
670.500 
     
1490.500 
      
508.500 
     
1328.500 
       
583.500 
     
1403.500 
          
316.500 
        
1136.500 
          
610.500 
        
1430.500 
Z -1.251 -2.817 -2.153 -4.699 -1.928 
Asymp. Sig. (2-tailed) .211 .005** .031* .000** .054 
*p <0.05 **p <0.01 
The table shows significant scores on the domains of appearance 
orientation (p< 0.01), Body Area Satisfaction (p <0.05), Over Weight 
Preoccupation(p <0.01) and Self Classified Weight(p <0.05). These 
scores were significantly lower in post mastectomy groups implying 
decreased body image in all these domains when compared to post 
hysterectomy group.   
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Correlation of age with depression, anxiety, body image and global 
quality of life  
Table :    9     Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho AGE 
Correlation 
Coefficient 
-.009 -.112 -.268 .000 
Sig. (2-tailed) .954 .491 .094 1.000 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
The above table shows no significant association between age and 
depression, anxiety, body image disturbance and quality of life. 
Table : 10        Post hysterectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho AGE 
Correlation 
Coefficient 
-.390* -.114 -.618** .197 
Sig. (2-tailed) .013 .483 * .000 .224 ** 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
The above table shows significant association between age and 
depression (p<0.05) and body image disturbance (p <0.01) in post 
hysterectomy group. There was no significant association of age with 
anxiety and quality of life. 
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Correlation of educational status  with anxiety, depression, body 
image and global quality of life 
Table :  11    Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho 
EDUCA
TION 
Correlation 
Coefficient 
.004 .058 
        
.137 
.031 
Sig. (2-tailed) .978 .724 398 .847 
N 40 40 40 40 
*p <0.05 **p <0.01 
There was no significant association between the educational status and 
anxiety, depression, body image and global quality of life scores. 
Table :   12      Post hysterectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho EDU 
Correlation 
Coefficient 
.129 .044 .320* -.025 
Sig. (2-tailed) .428 .789 .044 .878 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
There is significant correlation between educational status and 
body image disturbances in post hysterectomy group, implying that 
educated women had more body image disturbances. No significant 
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association is found with depression, anxiety and global quality of life in 
this group. 
Correlation of occupation with depression, anxiety, body image and 
global quality of life  
Table : 13 Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho OCCU 
Correlation 
Coefficient 
.085 .186 .240 .014 
Sig. (2-tailed) .600 .251 .135 .934 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
There was no significant association between occupation and depression, 
anxiety, body image and global quality of life in post mastectomy group. 
Table :  14   Post hysterectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho OCCU 
Correlation 
Coefficient 
-.111 -.123 -.031 .118 
Sig. (2-tailed) .494 .449 .849 .470 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
There is no significant correlation between occupation and depression, 
anxiety, body image disturbance and quality of life. 
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Correlation  of socio economic status with depression, anxiety, body 
image and global quality of life  
Table :15    Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho SES 
Correlation 
Coefficient .100 .078 .114 -.118 
Sig. (2-tailed) .539 .632 .482 .466 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
Correlation of socioeconomic status with depression, anxiety, body 
image disturbance and quality of life shows no significant association in 
post mastectomy group. 
Table  :  16   Post hysterectomy group 
 
Spearman ‘s rho HAM D HAM 
A 
BIS QL2 SES 
 SES 
Correlation Coefficient .019 .112 .266 -.012 1.000 
Sig. (2-tailed) .910 .491 .098 .941 . 
N 40 40 40 40 40 
*p <0.05 **p <0.01 
Correlation of socioeconomic status with depression, anxiety, body 
image disturbance and quality of life shows no significant association in 
post hysterectomy group. 
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     Correlation of stage of the disease  with anxiety, depression, body 
image and global quality of life  
Table :  17      Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho STAGE 
Correlation Coefficient .278 .269 .118 -.159 
Sig. (2-tailed) .083 .093 .468 .326 
N 40 40 40 40 
 
*p <0.05 **p <0.01 
In this study, there was no significant association between stage of the 
disease and depression, anxiety, body image and global quality of life in 
post mastectomy group . 
Table :  18  Post hysterectomy group 
 HAM D HAM A BIS QL2 
Spearman's 
rho 
STAG
E 
Correlation 
Coefficient 
.009 -.022 -.160 -.204 
Sig. (2-tailed) .957 .892 .323 .208 
N 40 40 40 40 
     
 
*p <0.05 **p <0.01 
In this study, there was no significant association between stage of the 
disease and depression, anxiety, body image and global quality of life 
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 Correlation of treatment modality with anxiety, depression, body 
image and global quality of life   
Table  :  19  Post mastectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho 
TREATM
T 
Correlation Coefficient -.058 -.126 -.151 .294 
Sig. (2-tailed) .721 .440 .353 .066 
N 40 40 40 40 
*p <0.05 **p <0.01 
There was no significant association between the treatment modality and 
anxiety, depression, body image and global quality of life scores in post 
mastectomy group. 
Table : 20   Post hysterectomy group 
 HAM D HAM A BIS QL2 
Spearman's rho 
TREATM
ENT 
Correlation Coefficient .105 .076 .162 -.235 
Sig. (2-tailed) .517 .640 .318 .145 
N 40 40 40 40 
     
*p <0.05 **p <0.01 
There was no significant association between the treatment modality and 
anxiety, depression, body image and global quality of life scores in post 
hysterectomy group. 
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   Correlation of body image disturbances with anxiety and 
depression 
Table  : 21        Post mastectomy group 
 HAM D HAM A  
 BIS 
Correlation 
Coefficient 
.550** .662**  
Sig. (2-tailed) .000 .000**  ** 
N 40 40  
      
 
**. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 0.05 level (2-tailed). 
Body image disturbance is found to have significant association with depression 
(HAM D   p <0.01)  and anxiety(HAM A – p<0.01) 
Table : 22     Post hysterectomy group 
 HAM D HAM A 
 BIS 
Correlation Coefficient .457 .346** * 
Sig. (2-tailed) .003 .029** * 
N 40 40 
*. Correlation is significant at the 0.05 level (2-tailed). 
 **. Correlation is significant at the 0.01 level (2-tailed) 
 
Body image disturbance is found to have significant association with 
depression (HAM D – p <0.01)  and anxiety(HAM A – p<0.05). 
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Comparison of  body image disturbances with  quality of life  
Table : 23   Post mastectomy group. 
  QOL FS 1 SS 1 FS 2 SS2 
B
I
S 
 
Correlation 
Coefficient 
Sig. (2-tailed) 
N 
-.349* -.413** .418 -.525** -.097 ** 
.027* .008** .007** .000 .553 ** 
40 40 40 40 40 
   
**. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 0.05 level 
(2-tailed). 
The scores on Body Image Scale shows significant negative correlation 
with Global Health Status, (p <0.05) , Functional Scale 1,general(p 
<0.01) and Functional Scale 2, breast specific(p<0.01), and significant 
positive correlation with Symptom Scale 1,general(p <0.01).  
Table :  24   Post hysterectomy group 
 QL2 FS1-T SS1-T FS2-T SS2-T 
Spearman's rho BIS 
Correlation 
Coefficient 
-.367* -.579** .230 -.326* .117 
Sig. (2-tailed) .020 .000* .153 ** .040 .470 * 
N 40 40 40 40 40 
*p <0.05 **p <0.01 
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The scores on Body Image Scale is found to have negative correlation 
with Global health Status and functional scales: positive correlations with 
symptom scales , with significant values in Global Health Status(p<0.05), 
Functional scale 1, general (p <0.01), functional scale 2, endometrium 
specific (p<0.05). 
     Correlation of body image disturbances with functional domains 
Table  : 25   Post mastectomy group 
 PF2 RF2 EF CF SF 
          BIS  
Correlation 
Coefficient 
-.113 -.026 -.309 -.305 .468** 
Sig. (2-tailed) .489 .872 .052 .056 
 
.002
 
** 
N 40 40 40 40 40 
. *p <0.05 **p <0.01 
 
The above table shows negative correlation between body image 
disturbances and specific functional domains namely physical 
functioning, role functioning, emotional functioning, cognitive 
functioning and social functioning with significant values in social 
functioning (p <0.01) 
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Table : 26     Post hysterectomy group 
 PF2 RF2 EF CF SF 
 BIS 
Correlation 
Coefficient 
-.339* -.343* -.342* -.379* -.260 
Sig. (2-tailed) .032 .030* .031* .016* .106 * 
N 40 40 40 40 40 
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
 
The scores on Body Image Scale is found to have negative correlation 
with specific functional domains  - physical, role, emotional, cognitive 
and social; with values reaching statistical significance in physical 
functioning (p < 0.05), role functioning (p < 0.05), emotional 
functioning(p < 0.05) and cognitive functioning(p < 0.05) . 
                Correlation of depression with quality of life – 
Table  : 27  Post mastectomy group 
 QL2 FS1-T SS1-T FS2-T SS2-T 
 
HAM 
D 
Correlation 
Coefficient 
 
-.412** 
-.205 .434** -.428** .100 
Sig. (2-tailed) .008 .204 ** .005 .006** .538 ** 
N 40 40 40 40 40 
**. Correlation is significant at the 0.01 level (2-tailed).  
*. Correlation is significant at the 0.05 level (2-tailed). 
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The scores on HAM D shows negative correlation with global health 
status and functional scales and positive correlation with symptom scales 
with significant values in global health status(p <0.01), functional 
subscale 2, breast specific (p <0.01)  and symptom scale 1, general(p 
<0.01 ).  
Table : 28  Post hysterectomy group 
 
 QL2 FS1-T SS1-T FS2-T SS2-T 
Spearman's rho 
HAM 
D 
Correlation 
Coefficient 
-.350* -.335* .237 -.071 .218 
Sig. (2-tailed) .027 .035* .141 * .664 .176 
N 40 40 40 40 40 
 
*. Correlation is significant at the 0.05 level (2-tailed).  
**. Correlation is significant at the 0.01 level (2-tailed).  
The above table shows that the scores on HAM D  is found to have 
negative correlation with Global health Status and functional scales: 
positive correlations with symptom scales , with significant values in 
Global Health Status(p <0.05), Functional scale 1, general (p <0.05). 
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                 Correlation of depression with functional domains 
Table  : 29  Post mastectomy group 
 PF2 RF2 EF CF SF 
Spearman's 
rho 
HAM 
D 
Correlation 
Coefficient 
-.042 -.026 -.123 -.349* -.157 
Sig. (2-tailed) .797 .873 .448 .027 .332 * 
N 40 40 40 40 40 
**. Correlation is significant at the 0.01 level (2-tailed).  
*. Correlation is significant at the 0.05 level (2-tailed). 
Scores on HAM D shows negative correlation of depressive scores 
with specific functional domains with significant values in cognitive 
functioning (p<0.05 ) 
Table : 30 Post hysterectomy group 
 PF2 RF2 EF CF SF 
Spearman's 
rho 
HAM 
D 
Correlation 
Coefficient 
-.010 -.047 -.247 -.267 -.091 
Sig. (2-tailed) .953 .774 .125 .096 .575 
N 40 40 40 40 40 
*. Correlation is significant at the 0.05 level (2-tailed).  
**. Correlation is significant at the 0.01 level (2-tailed). 
 
The scores on depression scales are found to have negative correlation 
with specific functional domains  - physical, role, emotional, cognitive 
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and social; with none of the values reaching statistical significance in 
them. 
Correlation of anxiety with quality of life 
Table  : 31  post mastectomy group 
 
  
ANXIETY 
 QL2 FS 1 SS 1 FS 2 SS 2 
Correlation Coefficient .729 -.482** .547** -.428** -.012 ** 
Sig. (2-tailed) .000 .002** .000** .006** .940 ** 
N 40 40 40 40 40 
  
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
         The above table shows HAM A scores to have negative 
correlation with  negative correlation with global health status and 
functional scales and positive correlation with symptom scale 1, with 
significant values in  global health status(p < 0.01), functional subscale 
general(p< 0.01), breast specific  (p < 0.01) and symptom scale 1, 
general (p < 0.01).  
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Table : 32 Post hysterectomy group 
 QL2 FS1-T SS1-T FS2-T SS2-T 
        HAM A  
 
Correlation 
Coefficient 
-.271 -.252 -.021 -.074 -.003 
Sig. (2-tailed) .091 .116 .900 .649 .987 
N 40 40 40 40 40 
      
*. Correlation is significant at the 0.05 level (2-tailed).  
**. Correlation is significant at the 0.01 level (2-tailed). 
 
       There is no statistically significant correlation between Anxiety 
scores and the quality of life subscales, namely Global health Status, 
functional scales 1& 2 and symptom scales 1 & 2.  
               Correlation of  anxiety with functional domains  
Table  : 33   Post mastectomy group 
 PF2 RF2 EF CF SF 
 HAM 
A 
Correlation 
Coefficient 
-.325* -.185 -.302 -.461** -.267 
Sig. (2-tailed) .041 .253 .059 .003 .096 ** 
N 40 40 40 40 40 
**. Correlation is significant at the 0.01 level (2-tailed).  
*. Correlation is significant at the 0.05 level (2-tailed). 
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The above table shows negative correlation between anxiety and 
functional domains with significant values in Physical functioning 
and cognitive functioning. 
Table : 34 Post hysterectomy group 
 PF2 RF2 EF CF SF 
HAM A  
Correlation 
Coefficient 
-.204 -.328* -.225 -.068 .016 
Sig. (2-tailed) .207 .039 .163 * .677 .922 
N 40 40 40 40 40 
      
*. Correlation is significant at the 0.05 level (2-tailed).  
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Scores in HAM A ( Anxiety Scale) shows significant negative correlation 
with role functioning (p <0.05) in post hysterectomy group. 
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                                      DISCUSSION 
 
               Psychiatric morbidity is one of the major areas of concern in 
patients with cancer.  But it is often underdiagnosed and under treated. 
Treatment protocol generally is based on management of the disease per se 
and its complications. Patient’s productivity and efficient functioning is one 
area which is being overlooked, especially in developing countries. Also 
there is decreased awareness among general population about the perception 
of the disease and treatment modalities.  Apart from the disease, the 
treatment modalities affect the quality of life in cancer patients. There is a 
common assumption among common people that surgery is “THE” most 
effective treatment and is considered as the pinnacle of all treatment 
modalities. It is held in awe by people and is dreaded the most, however 
minor it may be , the effect of this single mode of treatment alone is 
enormous and combined with other treatment modalities, which is inevitable 
for malignancy nowadays, there is definite impairment in psychological 
functioning of the patients.    
              This study was conducted to elucidate and compare the effects of 
surgery of the two common and specific feminine cancers on the body 
image disturbances, psychiatric morbidity and quality of life. Few results 
quoted in previous studies were replicated in this study.   
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Body image disturbances were assessed in both the groups using 
Body Image Scale(BIS) and Multidimensional Body Self Relations 
Questionnaire – Appearance Scales(MBSRQ- AS). They were found to be 
higher in both the groups. Comparing the means of two groups revealed 
significant difference between the groups(p<0.05, indicating that body 
image disturbances were higher in post mastectomy group (median – 10.00) 
than post hysterectomy group(median – 7.00). 
A study by Keskin et al, 2011, on “depression, body image, sexual 
problems and spouse relationships” on 94 patients, 42 who have 
undergone mastectomy and 52, hysterectomy revealed  the mean BIS  
scores to be low in both the groups and was found to be lower in 
mastectomy group than hysterectomy group, but not upto significant 
levels.            
              Among the body image subscales, physical attractiveness was 
predominantly negatively affected in mastectomy group. (Alicikus et al 
2009). In this study, “feeling less feminine and less whole, dissatisfaction 
with body and appearance of scar ” were predominant in mastectomy 
group; while “feeling less feminine and dissatisfaction with the 
appearance of the scar” was reported more in hysterectomy group. Avis 
et al 2004, Fobair et al 2006 reported that a woman’s perception of loss 
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directly correlates with the negative body image following both the 
surgeries. 
      A study conducted by Akkaya et al (2011) on the impact of body 
image on (QOL) quality of life and mood in mastectomised patients and 
amputees concluded that though mastectomy was not related to loss of 
physical function when compared to leg amputees, the distortion of body 
image was far worse than the latter group and this had a direct negative 
impact on Quality Of Life. 
          This supports the view that  body image and concept of life 
depends on internal factors than external factors, as explained by the 
author. This could be also be a possible explanation for no significant 
differences among mastectomy and hysterectomy patients in some 
studies.  The presence of significant difference in this study could be due 
to other factors such as age and parity which are important predictors of 
body image disturbances.(Harcourt et al 2003). In this study there is 
significant negative correlation between age and depression(0.013) and 
body image disturbances(0.000). 
          There was no association in  both the groups  in context to the 
socio demographic variables except for educational status in post 
hysterectomy group in this study. Educational status was found to have 
significant positive correlation with body image scores(p<0.05), 
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indicating greater impairment in educated group. This was in 
contradiction to the previous study by Alicikus et al, 2009  in which  
educational status was found to influence treatment decision making 
and was  reported to be an important predictor for stress;  less formal 
education implying poorer psychological  adjustment. It directly 
affected the cognitive appraisal  of the  new stressful situation.  
              There was no significant association between clinical 
correlates( like the stage of the disease, treatment modalities, sexual 
dysfunction, menopausal states and family history of psychiatric 
disorders and malignancies)   and body image disturbances in both the 
groups.   
                 In a study by Shoma et al 2009 in breast cancer patients 
assessing the body image and decision making for the type of surgery, it 
was reported that post menopausal women had lesser body image 
distress in conservation surgery group. Alicikus et al 2009 discussed the 
relationship between treatment modalities and  body image disturbances 
and sexual dysfunctions. He reported that about 50% developed these 
symptoms following surgery and another 24, after the initiation of 
Chemotherapy. This stresses on the need for timely intervention. It is 
also essential to include quality of life as one of the baseline 
assessments for all patients. A review conducted on this issue revealed 
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that the most significant factor affecting body image following adjuvant 
chemotherapy was ovarian damage (Biner et al,. 1996).   
               Using  Multidimensional Body Self Relations Questionnaire – 
Appearance Scales(MBSRQ- AS), significant differences were found in 
the domains of Appearance Orientation, Body Area Satisfaction Scale 
and  Overweight preoccupation among the groups with lesser appraisal of 
body image in post mastectomy patients than the other group. This 
further confirms significantly higher body image disturbances in this 
group.  
       Psychiatric morbidity was present in 57.5%(n = 23) and 55.0%(n = 
22) in mastectomy and hysterectomy groups. Among them,  in 
mastectomy group, 34.8%(n=8) had depression, 21.7%(n=5) had anxiety, 
34.8%(n= 8) had mixed anxiety and depression and 8.7%(n= 2) had 
adjustment disorder. In hysterectomy group, 40.9%(n=9) had depression, 
18.2%(n=4) had anxiety,27.3%(n=6) had mixed anxiety and depression 
and 13.6%(n=3) had adjustment disorder. There was no significant 
difference in  psychiatric morbidity (depression and anxiety scores) 
among both the groups. Anxiety and depression along with impaired 
physical and sexual functioning followed treatment with surgery. 
(Ranneker et al, 1952 ,  Bard et al , 1955). 
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       It was reported by Shaheenshah et al in 2007 that young women 
undergoing hysterectomy as a form of cancer treatment exhibited higher 
levels of anxiety and depression both before and after the surgery. 
      Rohan Dilip and Prakash Appaya (2010)  studied the psychiatric 
disorders using PRIME-MD PHQ in gynecological cancer patients.  They 
reported that psychiatric disorders were seen in 44% of them,  the most 
common being mood disorders which was seen in 25.7%.  16.8% showed 
anxiety disorders.  34.4% showed major depression which was more 
common in cancer patients than their benign counterparts.  The current 
study reported a higher incidence of psychiatric morbidity than this  
study.   
     In this study there was no significant correlation between socio 
demographic data and clinical correlates with psychiatric morbidity. 
One study by Dean (1987) reported relationship between surgical 
treatment and psychological distress.  Chemotherapy  was found to have 
better outcome in terms of psychiatric morbidity than mastectomy. 
Nowadays, chemotherapy is only given as an adjuvant to surgery. 
Depression is found to be relevant in 11-50% of terminally ill 
patients (Joffe et al, 1986).  35-45% of cancer patients developed 
clinically significant psychiatric morbidity of which 68% comprised of 
adjustment disorders, 13% major affective disorder followed by organic 
mental disorders (4%), personality disorders (3%), anxiety disorders 
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(2%).  (Dean, 1988, faibes et al, 1984). One  study by Kudel et al (2008) 
showed that 17.4% of the women experienced the phantom breast 
syndrome even almost  6 years after mastectomy.  
   Sexual dysfunction is one area which is closely associated with 
body image and sexuality. It was present in 37.5%(n=15) in post 
mastectomy group and 42.5%(n= 17). Though it was higher in 
hysterectomy group, it did not attain significant levels. 
              According to Dizon 2009, 90% of women undergoing treatment 
for breast cancer experience sexual dysfunction. Ganz et al, 1998 
reported that subjective sense of emotional well being was an important 
predictor of sexual dysfunction. After hysterectomy, the loss of the uterus 
has been shown to decrease sexual pleasure and interest.  According to 
Dinnerstein et al (1977) 37% of the women after hysterectomy showed 
decreased interest in sexual relationships. 
                    In contrary, Humphries (1980) reported that no change was 
felt by many women. Kruger et al (1979) found that sexual satisfaction is 
the best predictor of sexual status after hysterectomy.75% of the women 
undergoing  hysterectomy for benign conditions expressed relief after the 
surgery and showed that their self concept was not changed adversely 
after hysterectomy.  But that was not the state in malignant conditions in 
which the fear of the illness as well as the  side effects of the adjuvant  
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therapies contribute more to sexual dysfunction. It was reported in a 
study , Keskin et al 2011 , that women with hysterectomy had higher 
levels sexual dysfunction, probably due to the physical effects of the 
surgery and radiotherapy. This was corroborated in another study by 
Bruner and Boyd, 1998. They benefit from behaviourally oriented 
therapies. 
                Quality of life was found to be impaired in both the groups, 
with hysterectomy patients having greater impairment in Global Health 
Status and Functional Scale 1(general) as measured by EORTC  QLQ 
C30. In this there was significant difference in functional scale 1(p 
<0.005). 
               With the advancement of diagnostic and treatment facilities, it 
is expected the same could be said about the quality of life. But reality is 
that early detection and management implies that the patient survives 
long enough to experience the complications of the disease and treatment 
modalities. (Alicikus et al 2009). In his study(n= 112), “psychosexual 
and body image aspects of quality of life in Turkish breast cancer 
patients”, the author says that the aim of assessing quality of life is to 
understand and evaluate patients’ perspectives which differs significantly 
from one another and from the treating physician. The author also 
emphasis the need to take into account various factors – socio economic, 
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cultural, religious and educational background which affects a patient’s 
quality of life. 
                 In the present study, there was no significant association 
between Quality of life (QOL) and socio demographic profile and clinical 
correlates. This was in contradiction to previous studies which  showed 
varied results. 
               Fatma et al 1997, studying the effects of different treatment 
modalities on quality of life in breast cancer patients, found no significant 
association between the menopausal status and the quality of life, but the 
age of the patient correlated negatively with impairment in functioning in 
all domains, especially in social interaction and disease/treatment related 
symptoms. It was also reported that higher the stage of the disease, 
greater the impairment in quality of living.  
             In the study by Saleha et al 2010, women younger than 50 yrs 
had better quality of living than older women. This was in contrast to the  
findings in body image disturbances in other studies where younger 
women had more disturbances. This indicates the complex interaction 
between these parameters. There was no significant association between 
education, socio economic and residential status with quality of life in 
this study. 
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       Women who were employed had better quality of living, probably 
because of their functional independence, increased social interaction and 
better consciousness about their health status.(Pandey et al 2005). 
      Type of treatment and menopausal status has a significant effect on 
occurrence of psychosexual problems (Alicikus et al, 2009).  These 
necessitate  the importance of including QOL in baseline assessments for 
all patients, so that appropriate help and rehabilitation be provided to 
necessary patients.                                                                    
               Evaluating the relationship between Body image disturbances, 
psychiatric morbidity and Quality of life, the following results were 
noted in the present study.    
                Body image was found to be significantly positively associated 
with depression and anxiety scores. (p<0.001 in both groups). Keskin et 
al 2011 also noted significant positive correlation  body image and 
depression. In a study conducted by Akkaya et al 2011, there was 
significant positive correlation between body image disturbances and 
level of depression and negative correlation with quality of life. 
Specifically, body image disturbances significantly affected physical 
functioning domain and not the emotional and social functioning 
domains. 
              BIS scores were significantly negatively associated with quality 
of life -  Global health Status, Functional Scale 1(general) and 2(breast 
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specific), Symptom Scale 1 and specific domains – social functioning in 
mastectomy patients, while in hysterectomy group it has significant 
negative correlation with Global health Status, Functional Scale 
1(general) and 2(breast specific) and in specific domains  of physical, 
role, Emotional and Cognitive functioning. 
            Scores in depression scale were  found to have significant 
negative correlation with quality of life -  Global health Status, 
Functional Scale 2(breast specific), Symptom Scale 1 and specific 
domains – cognitive functioning in mastectomy patients, while in 
hysterectomy group it has significant negative correlation with Global 
health Status, Functional Scale 1(general), while no significant 
correlation was found in specific domains. The greater impairment in 
mastectomy group could be due to complex interaction between body 
image disturbances and depression on quality of life. 
              Anxiety scores were significantly negatively associated with 
quality of life -  Global health Status, Functional Scale 1(general) and 
2(breast specific), Symptom Scale 1 and specific domains – physical and 
cognitive functioning in mastectomy patients, while in hysterectomy 
group it had significant negative correlations with role functioning. 
            Saleha et al 2010, in their study on “assessment of quality of life 
in breast cancer patients using EORTC QLQ questionnaire”, investigated 
the association between the individual subscales and Global Health 
Status QOL along with socio demographic data in 200 patients. It was 
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found that patients had better scores on the social and role functioning 
subscales than emotional functioning subscale. Their scores on breast 
specific symptom scale(SS2) – “breast symptoms, arm symptoms, upset 
by hair loss” were high indicating lower quality of life in this domain. 
                Emotional functioning(p=0.002) and body image(p=0.011) 
showed significant positive correlation with global quality of life, while 
the symptom scale 2 showed significant negative correlation with the 
same. 
                This study compares the body image disturbances, psychiatric 
morbidity and quality of life in two of the most common cancers in 
women. This study highlights the fact that  there are variations in these 
parameters though both the groups are comparable in various factors. 
Both the organs are gender specific and both denote feminity. But the  
psychological manifestation in the loss of these organs , though similar 
qualitatively, are different quantitatively. But on the whole, the study 
emphasises the need to evaluate psychological morbidity including body 
image disturbances, quality of life and personality  in baseline assessment  
while formulating treatment plan.  
                   It is possible to reduce morbidity and mortality to a 
significant extent when intervened at the right time. The awareness 
among treating physicians in other specialities enables prompt referrals to 
psychiatric services. Appropriate pharmacological and psychotherapeutic 
interventions can enhance the standard of living of the Cancer Survivors.   
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CONCLUSION 
1. There are body image disturbances in post mastectomy and post 
hysterectomy cancer patients. 
2. These disturbances are significantly higher  in post mastectomy 
group when compared to post hysterectomy group. 
3. Psychiatric morbidity (depression, anxiety, mixed anxiety and 
depression and adjustment disorders) is present in both the groups; 
but there is no significant difference between the two groups. 
4.  There is quality of life impairment- global and in specific domains 
in the two groups; but there is no significant difference between 
the two groups. 
5. Body image disturbances are found to have significant relation 
with psychiatric morbidity and quality of life impairment in both 
the groups with differences observed in specific domains. 
6. Psychiatric morbidity is found to have significant relation with 
quality of life impairment in both the groups with differences 
observed in specific domains. 
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7. There is significant positive correlation between educational status 
and body image disturbances in post hysterectomy patients. 
8. There is no significant correlation between socio demographic 
profile, clinical correlates and body image disturbances , 
psychiatric morbidity and quality of life in both the groups. 
9. There is significant negative correlation between  age and 
depression and body image disturbances in post hysterectomy 
group.  
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LIMITATIONS 
1. One of the limitations of this study is the smaller sample size in both 
the comparison groups. 
2. Being a cross – Sectional  study, one time  psychological assessment 
of the cancer patients  in the post operative scenario will not be 
sufficient for the long term diagnosis and treatment in these patients. 
3. The study being a comparison between two groups, including a control 
population can improve the validity of the study. 
4. Three of the scales used in this study are self administered 
questionnaires. As educational status was not included in the selection 
criteria, patients not having formal education were administered scales 
by the investigator. Two of the scales are not available in local 
language and not standardised to Indian population. 
5. Randomisation could not be done as patients were  being treated in 
separate hospitals.  
 
 
  
87 
 
FUTURE DIRECTIONS 
1. The present study is only a cross-sectional study.  So a longitudinal 
study with proper follow-up is the need for the future. 
2. The assessment of the psychological framework of the patients in 
the preoperative state should be considered for future studies 
3. Personality factors and the intelligence of the patients are to be 
evaluated in the future studies.  
4. The present study has highlighted the lack of standardised scales 
pertaining to the Indian Population in body image disturbances.   
Hence future studies  
should be conducted to formulate the scales to suit the 
socioeconomic and socio cultural background   of the Indian 
women. 
5. After assessment the patients have to be treated accordingly, and 
then  
reassessed for effectiveness of the current psychotherapeutic 
modalities available and also to discover newer methods of treatment 
for these cancer patients.   
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